Halo Collective (BST:A9KN) - Cotización, noticias y análisis

Resumen de acción A9KN

Engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States.

Acerca de la empresa

Análisis fundamental de A9KN
Puntuación del snowflake
Valoración	2/6
Crecimiento futuro	0/6
Rendimiento pasado	0/6
Salud financiera	6/6
Dividendos	0/6

Recompensas

Análisis de riesgos

Earnings have declined by 48.7% per year over past 5 years

Does not have a meaningful market cap (€1M)

Shareholders have been substantially diluted in the past year

Shares are highly illiquid

Competidores de Halo Collective Inc.

Biofrontera

XTRA:B8FK

€17.4m

SynBiotic

DUSE:SBX

€31.9m

Redx Pharma

DB:0RX

€65.0m

Cantourage Group

XTRA:HIGH

€58.9m

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Halo Collective
Precios históricos de las acciones
Precio actual de la acción	US$0.26
Máximo en las últimas 52 semanas	US$4.07
Mínimo de 52 semanas	US$0.066
Beta	1.96
1Cambio en 1 mes	0%
Variación en 3 meses	229.30%
Cambio de 1 año	-93.17%
3Variación en 3 años	-99.68%
Variación en 5 años	n/a
Variación desde la OPV	-99.83%

Noticias y actualizaciones recientes

Recent updates

Rentabilidad de los accionistas

	A9KN	DE Pharmaceuticals	Mercado DE
7D	0%	-1.8%	-1.8%
1Y	-93.2%	-12.8%	13.6%

Rentabilidad vs. Industria: A9KN underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.

Rentabilidad vs. Mercado: A9KN underperformed the German Market which returned 5.9% over the past year.

Volatilidad de los precios

Is A9KN's price volatile compared to industry and market?
A9KN volatility
A9KN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	7.9%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.5%
10% least volatile stocks in DE Market	2.4%

Precio estable de las acciones: A9KN's share price has been volatile over the past 3 months.

Volatilidad a lo largo del tiempo: Insufficient data to determine A9KN's volatility change over the past year.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
2016	276	Katie Field	www.haloco.com

Resumen de fundamentos de Halo Collective Inc.

¿Cómo se comparan los beneficios e ingresos de Halo Collective con su capitalización de mercado?
Estadísticas fundamentales de A9KN
Capitalización bursátil	€1.10m
Beneficios(TTM)	-€87.07m
Ingresos (TTM)	€26.08m

0.0x

Ratio precio-ventas (PS)

0.0x

Ratio precio-beneficio (PE)

¿Está A9KN sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de A9KN
Ingresos	US$28.34m
Coste de los ingresos	US$24.54m
Beneficio bruto	US$3.80m
Otros gastos	US$98.41m
Beneficios	-US$94.61m

Últimos beneficios comunicados

Sep 30, 2022

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	-1.39
Margen bruto	13.40%
Margen de beneficio neto	-333.86%
Ratio deuda/patrimonio	18.3%

¿Cómo se ha desempeñado A9KN a largo plazo?

Ver rendimiento histórico y comparativa

Resumen de acción A9KN

Recompensas

Análisis de riesgos

Competidores de Halo Collective Inc.

XTRA:B8FK

€17.4m

DUSE:SBX

€31.9m

DB:0RX

€65.0m

XTRA:HIGH

€58.9m

Historial de precios y rendimiento

Noticias y actualizaciones recientes

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

Second quarter 2022 earnings released: US$1.61 loss per share (vs US$11.41 loss in 2Q 2021)

Recent updates

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

Second quarter 2022 earnings released: US$1.61 loss per share (vs US$11.41 loss in 2Q 2021)

Halo Collective Inc. Appoints Katie Field as Chairman of the Board

Halo Collective Receives All Regulatory Approvals for Its Third Budega Dispensary in Hollywood, Halo's First Superstore

Halo Collective Inc. announced that it has received $6 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance and other investors

Halo Collective Inc. announced that it has received $5.999994 million in funding

Halo Collective Inc. Announces Management Changes

First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.56 loss in 1Q 2021)

Halo Collective Inc. Announces Resignation of Philip Van Den Berg as Chief Financial Officer

Halo Collective Inc. Receives Final Approvals from the Los Angeles Department of Cannabis Regulation & California Department of Cannabis Control and the State Department of Cannabis Control

High number of new directors

Full year 2021 earnings released: US$4.12 loss per share (vs US$7.27 loss in FY 2020)

Less than half of directors are independent

Halo Collective Announces Changes to Board of Directors

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. (OTCPK:HCAN.F) completed the acquisition of 1285826 B.C. Ltd. from 1337617 B.C. Ltd., 1253540 B.C. Ltd. and NKG Investments Ltd.

Halo Collective Inc. announced that it expects to receive CAD 14 million in funding from Alpha Blue Ocean Investment Group

Halo Collective Receives Local Approvals for Budega™ Dispensary in Los Angeles's Noho Arts District

Halo Collective Inc. (OTCPK:HCAN.F) entered into an agreement to acquire 1285826 B.C. Ltd. for $7 million.

Third quarter 2021 earnings released: US$0.40 loss per share (vs US$0.42 loss in 3Q 2020)

High number of new directors

High number of new directors

Halo Collective Inc. Announces the Official Launch of Ztrawberriez and 4 Prophets Premium Cannabis Flower

Halo Collective Inc. Announces FlowerShop, a Sensory-Care™ Brand Launches New Product Line, BUDVASE

Halo Collective Announces Reorganization of International Assets to Create Akanda

Halo Collective Inc. Provides Earnings Guidance for the Year 2021

Halo Collective Inc. Provides Sales Guidance for the Month Ended April 2021

Halo Collective Inc. announced that it expects to receive CAD 1 million in funding

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 10.000025 million.

PeakBirch Logic Inc. Announces Partnership with Halo Collective Inc. to Develop Functional Mushroom Line

Halo Collective Inc. Enters into Partnership with Nightingale Remedies (Nightingale) and PeakBirch Logic Inc

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 8.00154 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1275111 B.C. Ltd.

Halo Labs Inc. announced that it expects to receive CAD 2.25 million in funding

Chief Financial Officer recently sold €95k worth of stock

Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Third quarter 2020 earnings released: US$0.006 loss per share

Halo Labs Inc. Appoints Annmol Sidhu to the Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of CanMart Ltd from David Keith Dean and Darran William Quinn.

Fred Leigh Resigns to Halo Labs Inc.'s Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding Letter of Intent to acquire CanMart Ltd for CAD 4.6 million.

Halo Labs Inc. (OTCPK:AGEE.F) entered into an amended asset purchase agreement to acquire three operating KushBar retail cannabis stores from KushBar Inc. for CAD 3.4 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1265292 B.C. Ltd.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of the remaining 85.28% stake in Ukiah Ventures Inc. from Odyssey Trust Company and others.

Earnings released

Halo Labs Inc. (OTCPK:AGEE.F) entered into a share exchange agreement to acquire the remaining 85.28% stake in Ukiah Ventures Inc. for $6.5 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 66.7% stake in LKJ11 LLC.

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding agreement to acquire a dispensary in Los Angeles.

Rentabilidad de los accionistas

Volatilidad de los precios

Acerca de la empresa

Resumen de fundamentos de Halo Collective Inc.

0.0x

0.0x